INTERNATIONAL PATENT: NEURIMMUNE AG, ALEXION PHARMACEUTICALS, INC. FILES APPLICATION FOR "ANTI-TRANSTHYRETIN ANTIBODY, COMPOSITIONS COMPRISING SAID ANTIBODY AND METHODS FOR TREATING OR PREVENTING TRANSTHYRETIN-MEDIATED AMYLOIDOSIS"

GENEVA, May 27 -- NEURIMMUNE AG (Wagistrasse 188952 Schlieren), ALEXION PHARMACEUTICALS, INC. (121 Seaport BoulevardBoston, Massachusetts 02210) filed a patent application (PCT/EP2024/082486) for "ANTI-TRANSTHYRETIN ANTIBODY, COMPOSITIONS COMPRISING SAID ANTIBODY AND METHODS FOR TREATING OR PREVENTING TRANSTHYRETIN-MEDIATED AMYLOIDOSIS" on Nov 15, 2024. With publication no. WO/2025/104243, the details related to the patent application was published on May 22, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MICHALON, Aubin (Martinsbergstrasse 365400 Baden), SALZMANN, Michael (Hammerstrasse 10...